Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention.

ABSTRACT:

Background

Recurrent acute myocardial infarction requiring unplanned percutaneous coronary intervention (PCI) is one of the major adverse cardiovascular events (MACEs) in patients with acute coronary syndrome (ACS) after PCI. There is a continuing controversy about the association between serum cystatin C, a biomarker for the evaluation of renal function, and the prognosis of ACS patients following PCI. The retrospective study evaluated the association between serum cystatin C level and MACE in ACS patients after PCI.

Methods

Data were retrieved for 330 patients with ACS for primary PCI in a single center. Serum cystatin C levels were measured before PCI. All patients underwent regular follow-ups after PCI, and the studied endpoint was MACE, defined as the need for a repeat

SUBMITTER: Xiao Z 

PROVIDER: S-EPMC11384458 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature